Cargando…

Association between PD‐L1 expression and initial brain metastasis in patients with non‐small cell lung cancer and its clinical implications

BACKGROUND: Brain metastases frequently occur in patients with non‐small cell lung cancer (NSCLC) resulting in a poor prognosis. Here, we investigated the association between PD‐L1 expression and brain metastasis in patients with NSCLC and its clinical significance. METHODS: A total of 270 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kyoungmin, Choi, Yoon J., Kim, Jung S., Kim, Dae S., Lee, Sung Y., Shin, Bong K., Kang, Eun J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327696/ https://www.ncbi.nlm.nih.gov/pubmed/34121347 http://dx.doi.org/10.1111/1759-7714.14006

Ejemplares similares

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
por: Kim, Chan, et al.
Publicado: (2016)

Pleural or pericardial metastasis: A significant factor affecting efficacy and adverse events in lung cancer patients treated with PD‐1/PD‐L1 inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2018)

Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
por: Kim, Dong Ha, et al.
Publicado: (2019)

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study
por: Choi, Myeong Geun, et al.
Publicado: (2021)

Programmed cell death ligand‐1 protein expression and CD274/PD‐L1 gene amplification in colorectal cancer: Implications for prognosis
por: Lee, Kyu Sang, et al.
Publicado: (2018)

Prognostic implications of PD-L1 expression in patients with angiosarcoma
por: Lee, Jii Bum, et al.
Publicado: (2021)

Non-small Cell Lung Cancer Initially Presenting with Intracardiac Metastasis
por: Kim, Jung Han, et al.
Publicado: (2005)

Solitary Small Bowel Metastasis from Breast Cancer
por: Choi, Jung Eun, et al.
Publicado: (2011)

Reliability of PD-L1 assays using small tissue samples compared with surgical specimens
por: Kim, Insu, et al.
Publicado: (2019)

Small molecule activator of Nm23/NDPK as an inhibitor of metastasis
por: Lee, Jae-Jin, et al.
Publicado: (2018)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Methodology for Evaluation of Residual Stress Effect on Small Corner-Crack Initiation and Growth
por: Kim, Janghwan, et al.
Publicado: (2019)

Associations between missing teeth and the risk of cancer in Korea: a nationwide cohort study
por: Kang, Eun Joo, et al.
Publicado: (2023)

The risk of cardiovascular disease and stroke in survivors of head and neck cancer in Korea
por: Kang, Eun Joo, et al.
Publicado: (2022)

Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis
por: Hyun, Dong-gon, et al.
Publicado: (2020)

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2020)

Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer
por: Hong, Green, et al.
Publicado: (2022)

STING mediates nuclear PD-L1 targeting-induced senescence in cancer cells
por: Lee, Je-Jung, et al.
Publicado: (2022)

Bilateral Internal Auditory Canal Metastasis of Non-small Cell Lung Cancer
por: Kim, Chang-Hee, et al.
Publicado: (2015)

Immunomodulatory Effect and Bone Homeostasis Regulation in Osteoblasts Differentiated from hADMSCs via the PD-1/PD-L1 Axis
por: Lee, Seung-Cheol, et al.
Publicado: (2022)

Concurrent Diagnosis of Pulmonary Metastasis of Malignant Mixed Müllerian Tumor and Small Cell Lung Cancer
por: Lee, Young Jin, et al.
Publicado: (2012)

Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
por: Shin, Junghoon, et al.
Publicado: (2019)

Thymic Metastasis in Breast Cancer: A Case Report
por: Park, Sung Bin, et al.
Publicado: (2007)

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR
por: Kim, Seongjae, et al.
Publicado: (2023)

Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
por: Kim, Jung Ho, et al.
Publicado: (2016)

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors
por: Chang, Hyeyoon, et al.
Publicado: (2017)

Hemidystonia as an Initial Manifestation of Leptomeningeal Metastasis
por: Jung, Hyun-Jung, et al.
Publicado: (2009)

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
por: Lee, Shin Yup, et al.
Publicado: (2016)

Retrospective Molecular Epidemiology Study of PD-L1 Expression in Patients with EGFR-Mutant Non-small Cell Lung Cancer
por: Cho, Jong Ho, et al.
Publicado: (2018)

Small (<4 cm), Unclassified Renal Cell Carcinoma Presenting with Initial Bone Metastasis: A Case of a Metastatic Lesion Missed at the Initial Diagnosis
por: Lee, Seung Je, et al.
Publicado: (2012)

Clinicopathologic implication of PD-L1 gene alteration in primary adrenal diffuse large B cell lymphoma
por: Lee, Ki Rim, et al.
Publicado: (2022)

Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer
por: Kang, Eun Joo, et al.
Publicado: (2020)

Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
por: Kim, Su-Jung, et al.
Publicado: (2019)

Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer
por: Roper, Nitin, et al.
Publicado: (2021)

Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model
por: Lee, Eun-Ji, et al.
Publicado: (2021)

Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jung, Hae Il, et al.
Publicado: (2017)

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
por: Yoo, Shin Hye, et al.
Publicado: (2019)

BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody
por: Choi, Jong Rip, et al.
Publicado: (2020)

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
por: Kim, Yeorae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9saqs5kcb7ioh54og0gpqdgsk5